Menopause-Related Conditions
Menopause-Related Conditions
The decline in oestrogen during and after menopause increases the risk of several significant health conditions. Understanding these risks — and the evidence-based strategies to reduce them — empowers women to take a proactive approach to their long-term health.
For educational purposes only. Always consult your GP or specialist for diagnosis and treatment.
Osteoporosis
What is osteoporosis?
Osteoporosis is a condition in which bones become weak and brittle, significantly increasing the risk of fractures. Oestrogen plays a key role in maintaining bone density by inhibiting bone-resorbing cells (osteoclasts). After menopause, bone loss accelerates — women can lose up to 20% of their bone density in the first 5–10 years.
Risk factors
- Early or premature menopause
- Family history of osteoporosis or hip fracture
- Low body weight
- Smoking and excess alcohol
- Low calcium and vitamin D intake
- Prolonged corticosteroid use
- Sedentary lifestyle
Prevention and management
- Weight-bearing and resistance exercise
- Calcium: 1,000–1,200mg daily from food and supplements
- Vitamin D3: 1,000–2,000 IU daily
- Vitamin K2 (MK-7): 90–200mcg daily
- Magnesium: 300–400mg daily
- HRT: highly effective at preserving bone density during and after menopause
- DEXA scan: recommended for women with risk factors or early menopause
Cardiovascular Disease
Oestrogen has protective effects on the cardiovascular system — it supports healthy cholesterol levels, blood vessel flexibility, and blood pressure regulation. After menopause, the risk of heart disease increases substantially and eventually equals that of men.
Risk reduction strategies
- Mediterranean-style diet
- Regular aerobic exercise (150 minutes per week)
- Not smoking
- Maintaining a healthy weight
- Omega-3 fatty acids (1,000–2,000mg EPA+DHA daily)
- HRT (when started within 10 years of menopause) is associated with reduced cardiovascular risk
- Regular blood pressure, cholesterol, and blood glucose monitoring
Genitourinary Syndrome of Menopause (GSM)
GSM encompasses vaginal and urinary symptoms caused by oestrogen deficiency, including vaginal dryness, irritation, pain during sex, urinary urgency, frequency, and recurrent UTIs. It affects up to 50% of postmenopausal women and, unlike hot flushes, does not improve without treatment.
Treatment
- Topical oestrogen (vaginal cream, pessary, or ring): highly effective, minimal systemic absorption, safe for long-term use including in women with a history of breast cancer (discuss with oncologist)
- Vaginal moisturisers: used regularly (not just before sex) to maintain vaginal health
- Lubricants: used during sex to reduce discomfort
- Systemic HRT: also improves GSM symptoms
Type 2 Diabetes
Oestrogen supports insulin sensitivity. After menopause, insulin resistance increases, raising the risk of type 2 diabetes. Weight gain around the abdomen (common after menopause) further increases risk.
Risk reduction
- Low-glycaemic diet, regular exercise, and maintaining a healthy weight
- Magnesium and inositol support insulin sensitivity
- HRT may reduce the risk of type 2 diabetes in postmenopausal women
Cognitive Changes and Dementia Risk
Some research suggests that the menopause transition is associated with changes in brain function and increased long-term risk of Alzheimer's disease. Oestrogen has neuroprotective effects, and its decline may contribute to cognitive vulnerability.
Protective strategies
- Omega-3 DHA (200–500mg daily)
- Choline 450mg
- Regular aerobic exercise
- Cognitive engagement and social connection
- Quality sleep
- HRT (when started early in the menopause transition) may have neuroprotective effects
Thyroid Disorders
Thyroid disorders become more common after menopause, and their symptoms (fatigue, weight changes, mood changes, brain fog) overlap significantly with menopause symptoms. All women experiencing menopause symptoms should have thyroid function tested to rule out thyroid dysfunction as a contributing factor.